{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2022"],"condition":["colorectal cancer"],"disease":["Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/40030"],"location":["China"],"study_start_month":["5"],"repository":["ECRIN MDR"],"study_status":["Not yet recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Efficacy and safety of combination of fluoroquinolone and trifluridine in patients with MMS advanced colorectal cancer after failure of second-line therapy","description":"Interventions: Treatment group:Fluoroquinolone combined with trifluridine tipiracil\nPrimary outcome(s): Progression-free survival;Disease control rate\nStudy Design: Cross-sectional","dates":{"creation":"2022-05-15"},"accession":"40030","cross_references":{"Chinese Clinical Trial Register":["ChiCTR2200059983"]}}